Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in women, yet remains under-studied and under-recognised. Pregnancy acts as a ‘cardiovascular stress test’, with haemodynamic and hormonal changes that may unmask subclinical disease or precipitate decompensation in those with existing cardiac disease. Pregnancy-related metabolic complications are under-studied risk factors for future CVD. This review explores the complex interplay between pregnancy and CVD.
Yao, et al. “Pregnancy- the ultimate cardiovascular stress test.” npj Cardiovascular Health, 2026. doi:10.1038/s44325-026-00131-8.
@article{Yao2026,
title = {Pregnancy- the ultimate cardiovascular stress test},
author = {Yao and Victoria, Jessica and Zentner and Dominica and Chandrasekhar and Jaya and Mukherjee and Swati},
journal = {npj Cardiovascular Health},
year = {2026},
doi = {10.1038/s44325-026-00131-8},
url = {https://www.nature.com/articles/s44325-026-00131-8}
}
Fibroblast growth factor 21 (FGF21) is a key regulator in metabolic diseases. Serum FGF21 levels are significantly elevated in patients with hyperuricemia and correlate positively with uric acid. In hyperuricemic mice, FGF21 is...
Artificial intelligence (AI) in cardiology is rapidly expanding, but enthusiasm for anticipated benefits should be balanced by a more critical inspection of ethical concerns. In this state-of-the-art review, we discuss the four pillars...
Acute stroke alerts are frequently activated for non-cerebrovascular conditions, creating false positives that strain resources and increase diagnostic uncertainty. We developed machine learning models integrating large-language models,...
Circadian imbalance may contribute to hypertension, but its association with incident hypertension, genetic susceptibility, and molecular pathways remains unclear. This prospective study included 107,270 UK Biobank participants free of...